New York-based biotechnology

Nature, studied withscientific rigor.

GNT develops and translates botanical medicines, natural compounds, and advanced formulations for allergic and inflammatory diseases.

NIH-supported programs Scientist-led development
Medicinal botanicals and laboratory glassware in an analytical research laboratory
From traditional knowledgeto translational medicine

Focused on unmet needs in

Food allergy
Allergic asthma
Eczema
Eosinophilic esophagitis

A connected research model

Built to carry discovery forward.

Our work bridges traditional botanical knowledge with analytical chemistry, immunology, formulation science, and regulatory development.

01

Botanical discovery

Identifying natural compounds and multicomponent formulations with activity in allergy and inflammation.

02

Mechanism & delivery

Defining immunologic mechanisms and improving bioavailability through advanced formulation and nanomedicine.

03

Translation & quality

Connecting analytical quality control, preclinical evidence, CMC, and clinical development.

Translational programs

Research designed for real-world impact.

R43 · SBIR Phase I · 2019–2021

IgE Suppressing Berberine Nanomedicine for Treatment of Food Allergies

Establishing feasibility for a food-allergy nanomedicine program.

R44 · SBIR Phase II · 2023–2027

IgE-suppressing berberine nanomedicine

Advancing a potential treatment for food allergy.

R41 · STTR Phase I · 2023–2025

Xanthopurpurin analog development

Investigating small-molecule approaches for multiple food allergies.

Clinical translation

Botanical medicine research support

Connecting preclinical research, quality, and clinical development.

Scientific services

Deep expertise, practical support.

More than 30 years of experience across allergy, asthma, eczema, botanical medicines, CMC, analytical quality, PK/PD, and natural product development.

View capabilities
01CMC, HPLC & LC-MS quality systems
02PK/PD & translational study design
03Nanoparticle & product characterization

Work with GNT

Let’s advance better interventions together.

Start a conversation